307 related articles for article (PubMed ID: 12498801)
1. Biophysical properties of human antibody variable domains.
Ewert S; Huber T; Honegger A; Plückthun A
J Mol Biol; 2003 Jan; 325(3):531-53. PubMed ID: 12498801
[TBL] [Abstract][Full Text] [Related]
2. The influence of the framework core residues on the biophysical properties of immunoglobulin heavy chain variable domains.
Honegger A; Malebranche AD; Röthlisberger D; Plückthun A
Protein Eng Des Sel; 2009 Mar; 22(3):121-34. PubMed ID: 19136675
[TBL] [Abstract][Full Text] [Related]
3. Domain interactions in antibody Fv and scFv fragments: effects on unfolding kinetics and equilibria.
Jäger M; Plückthun A
FEBS Lett; 1999 Dec; 462(3):307-12. PubMed ID: 10622716
[TBL] [Abstract][Full Text] [Related]
4. Structure-based improvement of the biophysical properties of immunoglobulin VH domains with a generalizable approach.
Ewert S; Honegger A; Plückthun A
Biochemistry; 2003 Feb; 42(6):1517-28. PubMed ID: 12578364
[TBL] [Abstract][Full Text] [Related]
5. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
Chen Y; Stollar BD
J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
[TBL] [Abstract][Full Text] [Related]
6. The importance of framework residues H6, H7 and H10 in antibody heavy chains: experimental evidence for a new structural subclassification of antibody V(H) domains.
Jung S; Spinelli S; Schimmele B; Honegger A; Pugliese L; Cambillau C; Plückthun A
J Mol Biol; 2001 Jun; 309(3):701-16. PubMed ID: 11397090
[TBL] [Abstract][Full Text] [Related]
7. Construction of an scFv library by enzymatic assembly of V(L) and V(H) genes.
Kato M; Hanyu Y
J Immunol Methods; 2013 Oct; 396(1-2):15-22. PubMed ID: 23916870
[TBL] [Abstract][Full Text] [Related]
8. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
[TBL] [Abstract][Full Text] [Related]
9. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
Tan PH; Sandmaier BM; Stayton PS
Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949
[TBL] [Abstract][Full Text] [Related]
10. Construction of a large phage-displayed human antibody domain library with a scaffold based on a newly identified highly soluble, stable heavy chain variable domain.
Chen W; Zhu Z; Feng Y; Xiao X; Dimitrov DS
J Mol Biol; 2008 Oct; 382(3):779-89. PubMed ID: 18687338
[TBL] [Abstract][Full Text] [Related]
11. Sequence determinants of protein aggregation in human VH domains.
Dudgeon K; Famm K; Christ D
Protein Eng Des Sel; 2009 Mar; 22(3):217-20. PubMed ID: 18957405
[TBL] [Abstract][Full Text] [Related]
12. Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability.
Röthlisberger D; Honegger A; Plückthun A
J Mol Biol; 2005 Apr; 347(4):773-89. PubMed ID: 15769469
[TBL] [Abstract][Full Text] [Related]
13. Bovine IgM antibodies with exceptionally long complementarity-determining region 3 of the heavy chain share unique structural properties conferring restricted VH + Vlambda pairings.
Saini SS; Farrugia W; Ramsland PA; Kaushik AK
Int Immunol; 2003 Jul; 15(7):845-53. PubMed ID: 12807823
[TBL] [Abstract][Full Text] [Related]
14. Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune libraries.
Hanes J; Jermutus L; Weber-Bornhauser S; Bosshard HR; Plückthun A
Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14130-5. PubMed ID: 9826665
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of HEL4, a soluble, refoldable human V(H) single domain with a germ-line scaffold.
Jespers L; Schon O; James LC; Veprintsev D; Winter G
J Mol Biol; 2004 Apr; 337(4):893-903. PubMed ID: 15033359
[TBL] [Abstract][Full Text] [Related]
16. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
Wörn A; Plückthun A
Biochemistry; 1998 Sep; 37(38):13120-7. PubMed ID: 9748318
[TBL] [Abstract][Full Text] [Related]
17. Aggregation-resistant VHs selected by in vitro evolution tend to have disulfide-bonded loops and acidic isoelectric points.
Arbabi-Ghahroudi M; To R; Gaudette N; Hirama T; Ding W; MacKenzie R; Tanha J
Protein Eng Des Sel; 2009 Feb; 22(2):59-66. PubMed ID: 19033278
[TBL] [Abstract][Full Text] [Related]
18. Development of a human light chain variable domain (V(L)) intracellular antibody specific for the amino terminus of huntingtin via yeast surface display.
Colby DW; Garg P; Holden T; Chao G; Webster JM; Messer A; Ingram VM; Wittrup KD
J Mol Biol; 2004 Sep; 342(3):901-12. PubMed ID: 15342245
[TBL] [Abstract][Full Text] [Related]
19. Binders based on dimerised immunoglobulin VH domains.
Sepúlveda J; Jin H; Sblattero D; Bradbury A; Burrone OR
J Mol Biol; 2003 Oct; 333(2):355-65. PubMed ID: 14529622
[TBL] [Abstract][Full Text] [Related]
20. Contributions of CDR3 to V H H domain stability and the design of monobody scaffolds for naive antibody libraries.
Bond CJ; Marsters JC; Sidhu SS
J Mol Biol; 2003 Sep; 332(3):643-55. PubMed ID: 12963373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]